University of Pisa
Also known as: Antonio Barone | A.O.U. Pisana - P.O. di Cisanello | Azienda Ospedaliero Universitaria pisana | Azienda Ospedaliero, Universitaria Pisana | Azienda Ospedaliero Universitaria Pisana, Pisa Italy | Azienda Ospedaliero Universitaria Pisana, Pisa, Italy | Cardio-Thoracic and Vascular Dept, University of Pisa | Department of Clinical and Experimental Medicine, University of Pisa | Department of Obstetrics & Gynecology - University of Pisa | Department of Pediatrics, University of Pisa | Department of Translational Research and New Technologies in Medicine and Surgery - University of Pisa | Liver Transplantation Co-ordinating Section. Cisanello Hospital. (University of Pisa). | Oncologia Medica - Ospedale Santa Chiara Pisa | Oncology Department, Ospedale Santa Chiara, Trento | Ospedale Cisanello, Pisa | Ospedale Santa Chiara Pisa | Paola Anna Erba | Santa Chiara Hospital | Servizio di Fisiopatologia Respiratoria, Dipartimento Cardiotoracico, University of Pisa, Italy | Unit of Developmental Neurorehabilitation, Pisa University Hospital | Università di Pisa | Universita di Pisa, Italy | University Hospital Pisa, Italy | University of Pisa | University of Pisa, Internal medicine | University of Pisa Medical School Hospital, Pisa, Italy | University of Pisa, Pisa, Italy | University Pisa | U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Universitaria Pisana Dipartimento di Ricerca Traslazionale e Nuove Tecnologie - Università di Pisa Istituto Toscano Tumori
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1993Last known activity
Oct 1, 2025
Timeline
1340s
- Jan 1, 1343
University of Pisa— Founded
Drugs by trial phase (82 distinct, 68 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Brain Diseases
- Brain Ischemia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Cataract
- Chronic Disease
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Crohn Disease
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- Eye Diseases
- Eye Infections
- Fever
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Glucose Metabolism Disorders
- Graves Ophthalmopathy
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hypercholesterolemia
- Hypothermia
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infarction
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leiomyosarcoma
- Lung Diseases
- Lung Diseases, Obstructive
- Metabolic Diseases
- Multiple Myeloma
- Myocardial Infarction
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Pancreatic Neoplasms
- Paresis
- Pelvic Pain
- Pneumonia
- Polycystic Ovary Syndrome
- Postoperative Complications
- Prediabetic State
- Premature Ejaculation
- Prostatic Neoplasms
- Prostatitis
- Puberty, Precocious
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Eosinophilia
- Rectal Neoplasms
- Recurrence
- Shoulder Pain
- Thyroid Diseases
- Thyroid Neoplasms
- Ulcer
Recent trials (50)
- NCT07006194CollaboratorN/AOct 1, 2025
- NCT06733038OfficialPhase 3Nov 15, 2024
- NCT06578559OfficialPhase 2Jul 23, 2024
- NCT06270498CollaboratorPhase 4Mar 14, 2024
- NCT06270498Lead sponsorPhase 4Mar 14, 2024
- NCT06270498OfficialPhase 4Mar 14, 2024
- NCT06270498Sponsor investigatorPhase 4Mar 14, 2024
- NCT06332079OfficialPhase 2Mar 13, 2024
- NCT06236932CollaboratorN/ADec 29, 2023
- NCT06755489Sponsor investigatorN/AApr 17, 2023
- NCT06755489Lead sponsorN/AApr 17, 2023
- NCT05253846Overall official - principal investigatorPhase 2Jan 25, 2022
- NCT05360264CollaboratorPhase 2Jan 15, 2022
- NCT05049603Reponsible party - principal investigatorPhase 3Jan 1, 2022
- NCT05049603Lead sponsorPhase 3Jan 1, 2022
Details
- Founded
- Pisa, IT Jan 1, 1343
- Last known activity
- Oct 1, 2025